摘要
目的以两亲性材料壳聚糖-去氧胆酸聚合物为载体制备积雪草酸(AA)自组装胶束(AA-CS-DCA PMs),并研究胶束在大鼠体内的药动学特点。方法采用超声分散法构建AA-CS-DCA PMs,采用包封率、载药量、粒径、Zeta电位等指标对胶束进行表征,通过体外释放考察胶束的释药特性。进一步建立清醒大鼠胆汁引流模型,采用柱前衍生化HPLC方法测定胆汁中药物质量浓度,并通过达峰时间(t_(max))、峰浓度(C_(max))、药物排泄速率-时间曲线下面积(AUC0~t)评价口服胶束的体内药动学特点。结果所构建的载药胶束粒径为(70.5±9.8)nm,Zeta电位为(38.4±0.8)mV;药物AA包封率为(77.8±1.2)%,载药量达到(11.7±0.2)%;体外释放试验中,药物没有明显的突释现象,具有缓释特征。载药胶束经胆汁排泄的C_(max)(26.05±3.04)μg/h是对照组(原料药)(9.19±1.12)μg/h的2.8倍,tmax显著延长(2 h vs 1 h),体内消除明显减慢,其消除半衰期t_(1/2)(2.68±1.71)h是对照组(1.49±0.38)h的1.8倍。反映药物吸收程度的生物利用度AUC_(0～t),与对照组相比提高了200%[(99.05±12.83)μg vs(33.56±8.33)μg]。结论 AA经自组装胶束包封后,体内药物水平明显提高,作用时间延长,极大提高了AA的口服生物利用度。
Objective To prepare asiatic acid(AA) loaded chitosan-deoxycholic acid self-assembled micelles(AA-CS-DCA PMs) adopting chitosan-deoxycholic acid(CS-DCA) as carriers and investigate its pharmacokinetic characteristics in rats.Methods AA-CS-DCA PMs were prepared by ultrasonic dispersion method.The characteristics of micelles were evaluated by the distribution of particle size,Zeta potential,drug loading,encapsulation efficiency,and in vitro release.Model of bile drainage was established in conscious rats and pre-column derivatization HPLC method was used to determine the concentration of AA in bile.Moreover,the pharmacokinetics characteristics of AA-CS-DCA PMs in vivo was evaluated by tmax,Cmax and AUC_(0-t).Results The particle size was(70.5 ± 9.8) nm,the Zeta potential was(38.4 ± 0.8) mV,and encapsulation efficiency and drug loading were(77.8 ± 1.2)% and(11.7 ± 0.2)%,respectively.The in vitro release profile showed a sustained release property.In vivo study showed that Cmax of AA-CS-DCA group(26.05 ± 3.04) μg/h was 2.8 times higher than that of the control group(9.19 ± 1.12) μg/h; The tmax of AA-CS-DCA PMs group prolonged significantly(P < 0.05) in biliary excretion(2 h vs 1 h) and the elimination half-life t_(1/2) was 1.8 times of the control group [(2.68 ± 1.71) h vs(1.49 ± 0.38 h)].In addition,the AUC_(0-24 h) which reflected the degree of drug absorption increased by 200% compared with the control group [(99.05 ± 12.83) μg vs(33.56 ± 8.33) μg].Conclusion The chitosan-deoxycholic acid self-assembled micelles can raise the concentration of AA and prolong the retention time in vivo,which effectively improve the oral bioavailability of AA.
引文
[1]中国药典[S].一部.2015.
[2]王毅.积雪草苷类化合物对神经系统药理作用研究进展[J].药物评价研究,2016,39(1):136-142.
[3]冯霞,张雅雯,梁泽华,等.积雪草酸的大鼠在体肠吸收动力学研究[J].中国现代应用药学,2013,30(6):628-632.
[4]王策.积雪草苷对大鼠心肌缺血再灌注损伤的保护作用研究[J].药物评价研究,2015,38(2):151-155.
[5]张雅雯,尹丽娜,梁泽华,等.积雪草酸大鼠体内药动学考察[J].中国现代应用药学,2015,32(3):314-317.
[6]Shen C Y,Gu X C,Wang G Q,et al.Determination of asiatic acid in rat plasma by GC/MS[J].J Chin Mass Spectrom Soc,2006,27(3):155-159.
[7]Zheng X C,Wang S H.Determination of asiatic acid in beagle dog plasma after oral administration of Centella asiatica extract by precolumn derivatization RP-HPLC[J].J Chromatogr B,2009,877(5/6):477-481.
[8]Grimaldi R,De Ponti F,D'Angelo L,et al.Pharmacokinetics of the total triterpenic fraction of Centella asiatica after single and multiple administrations to healthy volunteers.A new assay for asiatic acid[J].JEthnopharmacol,1990,28(2):235-241.
[9]Aburahma M H.Bile salts-containing vesicles:Promising pharmaceutical carriers for oral delivery of poorly watersoluble drugs and peptide/protein-based therapeutics or vaccines[J].Drug Deliv,2016,23(6):1847-1867.
[10]Lai Y J,Zeng S,Wang S H.Study on the ADME of the bioactive constituents in Centella asiatica and the strategy for the improvement of their oral bioavailability[J].Chin J Mod Appl Pharm,2013,30(7):805-808.
[11]阙慧卿,陈洪,彭华毅,等.雷公藤内酯醇纳米脂质体涂膜剂制备研究[J].中草药,2016,47(20):3626-3631.
[12]谭梅娥,姜雯,曾诚,等.田蓟苷固体脂质纳米粒的优化及其在Caco-2细胞模型中的吸收和转运研究[J].中草药,2017,48(10):2051-2060.
[13]陈静怡,任翔,王晓辉,等.积雪草苷修饰脂质体在大鼠体内的药动学及组织分布研究[J].中草药,2017,48(21):4419-4424.
[14]Hubbell J A,Chilkoti A.Nanomaterials for drug delivery[J].Science,2012,337(6092):303-305.
[15]游倩倩,张怀敏,李丹,等.两亲性嵌段共聚物的自组装及载药胶束的研究[J].高分子通报,2013,6:51-56.
[16]张秀荣,关皎,赵阳,等.丝裂霉素两亲性壳聚糖聚合物胶束大鼠体内药动学及组织分布[J].中国药学杂志,2013,48(18):1569-1573.
[17]余敬谋,李永杰,王成润,等.聚乙二醇壳聚糖-胆固醇接枝物载多柔比星自聚集纳米粒的制备其大鼠体内药动学研究[J].中国药学杂志,2010,45(4):277-282.
[18]Leng D D,Han W J,Rui Y,et al.In vivo disposition and metabolism of madecassoside,a major bioactive constituent in Centella asiatica(L.)Urb[J].J Ethnopharmacol,2013,150(2):601-608.
[19]Marier J F,Vachon P,Gritsas A,et al.Metabolism and disposition of resveratrol in rats:extent of absorption,glucuronidation,and enterohepatic recirculation evidenced by a linked-rat model[J].J Pharmacol Exp Ther,2002,302(1):369-373.
[20]Rodríguez-Ortigosa C M,Banales J M,Olivas I,et al.Biliary secretion of S-nitroso glutat-hione is involved in the hypercholeresis induced by ursodeoxycholic acid in the normal rat[J].Hepatology,2010,52(2):667-677.
[21]Zong L,Qu Y,Luo D X,et al.Preliminary experimental research on the mechanism of liver bile secretion stimulated by peppermint oil[J].J Dig Dis,2011,12(4):295-301.
[22]黄夏樱,张雅雯,尹丽娜,等.积雪草酸脂质纳米粒的大鼠口服吸收研究[J].中国现代应用药学,2016,33(4):444-448.
[23]Agnihotri S A,Mallikarjuna N N,Aminabhavi T M.Recent advances on chitosan-based micro-and nanoparticles in drug delivery[J].J Control Release,2004,100(1):5-28.
[24]康安,梁艳,郝海平,等.新型促吸收剂研究进展—以细胞间紧密连接为靶点[J].药学学报,2007,42(11):1122-1128.
[25]Rafamantanana M H,Rozet E,Raoelison G E,et al.An improved HPLC-UV method for the simultaneous quantification of triterpenic glycosides and aglycones in leaves of Centella asiatica(L.)Urb(APIACEAE)[J].JChro B Analyt Technol Biomed Life Sci,2009,877(23):2396-2402.
[26]Lai S K,Wang Y Y,Hanes J.Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues[J].Adv Drug Deliv Rev,2009,61(2):158-171.
